Miscellaneous
This Podcast episode cannot get any closer to what personalized medicine is really about. Welcome Dr. Dan Rhodes, the founder and CEO of Strata Oncology, a leading precision oncology company leveraging state-of-the art genomics tools for more efficient cancer diagnostics and treatment. Dan is a bioinformatician by training and spent his entire career applying genomics to solving complex problems in oncology. Dan founded two very successful startups in this field and also has gathered vast experience working as a VP of Oncology Strategy at large corporations (Life Technologies and Thermo Fisher). This interview is full of deep insights on the state of genomic testing in cancer treatment and reflections on the future of precision oncology.◦ Tune into this episode to learn more about:◦ Dan’s journey from a PhD student to a serial biotech entrepreneur◦ Differences between working in a small start-up vs large organizations◦ Strata’s mission to determine best possible treatment for each cancer patient◦ Role of RNAseq in precision oncology◦ Approaches for highly-sensitive NGS of solid tumors◦ Paradigm shift in clinical trials for personalized therapeutics◦ Reimbursement landscape for cancer genomics◦ Potential of asymptomatic NGS screening in oncology◦ Dan’s vision for the future of precision oncologyMake sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com